Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Mild to Moderate Active Crohn's Disease
NCT00130390Phase 2Terminated
- Sponsor
- Romark Laboratories
- Start
- Aug 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in Crohn's disease, sponsored by Romark Laboratories. Started Aug 2005; status: terminated.
02
Drugs
nitazoxanide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00130390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130390.